InvestorsHub Logo
Followers 12
Posts 619
Boards Moderated 0
Alias Born 12/14/2018

Re: 10baggerz post# 339512

Tuesday, 12/15/2020 9:31:01 PM

Tuesday, December 15, 2020 9:31:01 PM

Post# of 687652
10Baggerz, Seems the Riddler answered his riddle (“What satisfies and benefits everyone? Figure that and you will have your answer.”)

He stated the company is “working their assess off” to get us TLD and “do it right” with the goal of getting “treatment to market” without FDA issues. He provided an example of a company that failed to properly report data which resulted in an FDA rejection and a 2 year delay in approval.


Indirectly he also implied that getting the messaging right is key, from the perspective of providing the enemies of the company with the smallest possible target after TLD is announced:

He talked about AF and how people like him do so much damage in convincing people who believe in the science to get fearful and sell.


AF’s idiotic post about mineral oil placebo after Amarin shared results sunk the stock on the following Monday. I imagine AF, Stuppy, Wick (remember their journal article comments) and others won’t be lobbing syringes of orange juice after TLD but balloons full of urine.

From my zen koan post:

Here’s an opinion worth two cents: Our current location on the timeline of this multi-year drama is post-unblinding, pre-TLD. At least one wrinkle is most likely to have surfaced in all this data and analysis and messaging.

It is to the benefit of shareholders of all classes to “get this right.” We only get one shot at doing the analysis right and messaging the TLD in the best possible manner.

Both aspects are critical. The FDA holds the knife to our throats and the response of NWBO’s enemies to TLD should always be taken into consideration.


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160134952

Keep an eye on Stuppy—he was a dodge ball champ in college.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News